Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection.

A NEW SPECIFIC COLOR REACTION OF HEXURONIC ACIDS

1947 • 2,137 citations

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

1977 • 1,745 citations

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

1980 • 865 citations

[Microdetermination of hydroxyproline with chloramine-T and p-dimethylaminobenzaldehyde].

1958 • 626 citations

Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors

1972 • 602 citations

Studies of the Proteins in Human Plasma Very Low Density Lipoproteins

1969 • 467 citations

Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.

1981 • 437 citations

Determination of Calcium and Magnesium in Urine by Atomic Absorption Spectroscopy

1961 • 371 citations

Comparison of current methods for high-density lipoprotein cholesterol quantitation.

1979 • 241 citations

Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, ageing, and disease

1945 • 217 citations

Verapamil suppresses atherosclerosis in cholesterol-fed rabbits

1983 • 198 citations

Calcium antagonistic drugs. Mechanism of action

1980 • 194 citations

Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.

1980 • 187 citations

Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits.

1983 • 134 citations

Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit

1984 • 133 citations

Pharmacology of agents that affect calcium. Agonists and antagonists.

1980 • 120 citations

The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits.

1978 • 108 citations

Electrophysiologic and hemodynamic effects of slow-channel blocking drugs

1982 • 89 citations

No effect of nifedipine on atherogenesis in cholesterol-fed rabbits.

1984 • 82 citations

The role of calcium antagonism in the therapeutic action of drugs

1979 • 74 citations

Modification of experimental atherosclerosis by calcium-channel blockers

1985 • 72 citations

Does nifedipine suppress atherogenesis in WHHL rabbits?

1984 • 67 citations

Effects of anticalcifying and antifibrobrotic drugs on pre-established atherosclerosis in the rabbit

1979 • 62 citations

The inhibitory effect of new diphosphonic acids on aortic and kidney calcification in vivo

1978 • 46 citations

Regression of atheroma in the rabbit

1977 • 41 citations

Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats

1984 • 36 citations

Cerebral atherosclerosis in Japanese

1971 • 25 citations

Changes in the connective tissue proteins, glycosaminoglycans and calcium in the arteries of the cynomolgus monkey during atherosclerotic induction and regression

1984 • 24 citations

“Calcium-antagonists” and antherosclerosis — basic studies and therapeutic implications

1983 • 23 citations

Verapamil suppresses atherosclerosis in cholesterol fed rabbits

1982 • 23 citations

The Whole Body Autoradiographic Studies on the Distribution of <SUP>14</SUP>C-Labeled New 1, 5-Benzothiazepine Derivative (<SUP>14</SUP>C-CRD-401) in Mice

1971 • 21 citations

Cerebral atherosclerosis in Japanese part 6: the interaction of plasma lipoproteins with glycosaminoglycans isolated from the cerebral arteries and aortas.

1981 • 9 citations

Arterial Calcium Metabolism, Hypertension and Arteriosclerosis

1981 • 8 citations

Influences of Ca2+ : Antagonist and Cyclic AMP on Vascular Smooth Muscle Cells in Culture

1985 • 3 citations